Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ong

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
Cureus|October 17, 2025
A Targeted Radionuclide Therapy Facility at a University Teaching Hospital in SingaporeKoon Liang Chia, Shao J Ong, Michael Ong, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 6, 2016
Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer-a systematic reviewRicardo Fernandes, Sasha Mazzarello, Brian Hutton, et al.
Annals of Global Health|June 22, 2019
Bridging the Gap: Including Patient Voices in Short-Term Medical Mission EvaluationsDiana Morales, Wendy Clay, Rebecca Khamishon, et al.
Critical Reviews in Oncology/Hematology|July 5, 2020
Potential insights from population kinetic assessment of progression-free survival curvesDavid J Stewart, Dominick Bosse, Andrew Robinson, et al.
Urologic Oncology|October 22, 2022
UnCHAARTED territory: The role of docetaxel rechallenge following chemohormonal therapy for metastatic castration-sensitive prostate cancerMary Mahler, Esmail Al-Ezzi, Noa Shani Shrem, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 21, 2015
Treatment of taxane acute pain syndrome (TAPS) in cancer patients receiving taxane-based chemotherapy-a systematic reviewRicardo Fernandes, Sasha Mazzarello, Habeeb Majeed, et al.
Cancer Medicine|November 18, 2022
A population-based study of factors associated with systemic treatment in advanced prostate cancer decedentsJennifer Leigh, Danial Qureshi, Ewa Sucha, et al.
The Oncologist|March 25, 2024
Real-World Evaluation of Primary Versus Secondary Prevention of Skeletal-Related Events in Metastatic Castration-Resistant Prostate CancerWilliam J Phillips, Fred Saad, Jennifer Leigh, et al.
Current Oncology (Toronto, Ont.)|December 24, 2025
Canadian Prostate Cancer Trends in the Context of PSA Screening Guideline ChangesAnna N Wilkinson, Larry F Ellison, Shary X Zhang, et al.
BMJ Quality & Safety|November 1, 2016
Development of a high-value care culture survey: a modified Delphi process and psychometric evaluationReshma Gupta, Christopher Moriates, James D Harrison, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
Cureus|October 17, 2025
A Targeted Radionuclide Therapy Facility at a University Teaching Hospital in SingaporeKoon Liang Chia, Shao J Ong, Michael Ong, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 6, 2016
Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer-a systematic reviewRicardo Fernandes, Sasha Mazzarello, Brian Hutton, et al.
Annals of Global Health|June 22, 2019
Bridging the Gap: Including Patient Voices in Short-Term Medical Mission EvaluationsDiana Morales, Wendy Clay, Rebecca Khamishon, et al.
Critical Reviews in Oncology/Hematology|July 5, 2020
Potential insights from population kinetic assessment of progression-free survival curvesDavid J Stewart, Dominick Bosse, Andrew Robinson, et al.
Urologic Oncology|October 22, 2022
UnCHAARTED territory: The role of docetaxel rechallenge following chemohormonal therapy for metastatic castration-sensitive prostate cancerMary Mahler, Esmail Al-Ezzi, Noa Shani Shrem, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 21, 2015
Treatment of taxane acute pain syndrome (TAPS) in cancer patients receiving taxane-based chemotherapy-a systematic reviewRicardo Fernandes, Sasha Mazzarello, Habeeb Majeed, et al.
Cancer Medicine|November 18, 2022
A population-based study of factors associated with systemic treatment in advanced prostate cancer decedentsJennifer Leigh, Danial Qureshi, Ewa Sucha, et al.
The Oncologist|March 25, 2024
Real-World Evaluation of Primary Versus Secondary Prevention of Skeletal-Related Events in Metastatic Castration-Resistant Prostate CancerWilliam J Phillips, Fred Saad, Jennifer Leigh, et al.
Current Oncology (Toronto, Ont.)|December 24, 2025
Canadian Prostate Cancer Trends in the Context of PSA Screening Guideline ChangesAnna N Wilkinson, Larry F Ellison, Shary X Zhang, et al.
BMJ Quality & Safety|November 1, 2016
Development of a high-value care culture survey: a modified Delphi process and psychometric evaluationReshma Gupta, Christopher Moriates, James D Harrison, et al.
Pageof 12